PRCT vs UFPT Stock Comparison
UFPT currently leads PRCT in this stock comparison, with AIQ scores of 68 vs 49. The clearest difference is value.
What is the main difference between PRCT and UFPT?
UFPT leads the current stock comparison as UFP Technologies, Inc., with the clearest separation coming from value and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
PROCEPT BioRobotics Corporation vs UFP Technologies, Inc.
UFPT leads
UFPT leads by 19 AIQ points, primarily on Value and Momentum, but the lead has narrowed from 25 points over 30 sessions.
Competitive: 3 of 5 evidence groups support UFPT, its lead is narrowing, and its current signal state is conflicted.
PROCEPT BioRobotics Corporation
UFP Technologies, Inc.
The Algovestiq AIQ Score currently favors UFPT over PRCT, 68 versus 49 as of Nov 18, 2026. UFPT's advantage is driven primarily by stronger value and momentum. UFPT also shows the weaker technical structure relative to its 50-day moving average. 3 of 5 covered evidence groups favor UFPT today, and the comparison is rated Competitive on stability: the leader's advantage has been narrowing. UFPT lead: Weakening — the AIQ differential moved from 25 to 19 points over 30 sessions. UFPT leads on all four AIQ factor dimensions. Value is itself one of those four, so a sweep is not explained by valuation alone — it deserves additional scrutiny for unmodeled catalysts, expectations or event risk.
Compare PROCEPT BioRobotics Corporation and UFP Technologies, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare PRCT and UFPT against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Value38 vs 61UFPT +23
- Momentum60 vs 81UFPT +21
- Quality45 vs 63UFPT +18
- Risk Resilience45 vs 56UFPT +11
3 of 5 evidence groups favor UFPT. UFPT’s edge is concentrated in value and momentum.
What changed since the last close
Latest scored session 2026-11-18, compared against the prior scored session 2026-11-17.
Largest factor move: Value -1, not enough on its own to move the overall score.
New signals
- Accumulation Pattern — bullish, volume, medium horizon (1.27x)
Largest factor move: Momentum +2
No signal started or stopped since the prior session; its 9 active signals are unchanged.
UFPT's lead widened by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — PRCT and UFPT both carry a full feed there.
The central trade-off
UFPT (UFP Technologies, Inc.): the stronger current systematic profile, led by value and momentum.
PRCT (PROCEPT BioRobotics Corporation): the counter-case, on technicals.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
UFPTUFPT on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
PRCTPRCT on combined revenue and EPS growth.
Value
UFPTUFPT on the peer-relative Value factor, by 23 points.
Momentum
UFPTUFPT on the Momentum factor, by 21 points.
Lower downside
UFPTUFPT on Risk Resilience, by 11 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | PRCT | UFPT | Note |
|---|---|---|---|
| Implied upside to target | +19.1% | — | Level |
| Target dispersion | 0% | — | Lower is tighter analyst agreement |
| Consensus | Hold | Buy | Context, not a primary driver |
| Analysts covering | 15 | 4 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 5 covered evidence groups favor UFPT. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | UFPT | 49 vs 68 |
| Fundamentals | Even | EPS growth 2.1% vs -1.1%; TTM ROE -8.1% vs 4.2%; gross margin 64.7% vs 28.9%; operating margin -33.6% vs 15.5% |
| Valuation | UFPT | Value 38 vs 61 |
| Technicals | PRCT | Price vs 50-day 29% vs 4.3%; vs 200-day 3.9% vs 21.2% |
| Risk Resilience | UFPT | Risk Resilience 45 vs 56 |
| Analyst expectations | Not covered | Not covered |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of PRCT and UFPT and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is wide at 19 points. (supports the conclusion holding)
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on UFPT.
How the comparison changed
120 daily snapshots · Jun 1 – Nov 18UFPT lead: Weakening — the AIQ differential moved from 25 to 19 points over 30 sessions.
- Today
- UFPT +19
- 49 vs 68
- 7 sessions ago
- UFPT +22
- 46 vs 68
- 30 sessions ago
- UFPT +25
- 45 vs 70
- 90 sessions ago
- UFPT +30
- 39 vs 69
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
4 bullish / 1 bearish / 2 neutral, conflicted
Only PRCT
- Death Cross Active — bearish, trend, long horizon (17.37%)
- Accumulation Pattern — bullish, volume, medium horizon (1.27x)
- Keltner Channel Breakout — bullish, volatility, short horizon
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
5 bullish / 2 bearish / 2 neutral, conflicted
Only UFPT
- Golden Cross Active — bullish, trend, long horizon (16.39%)
- Beta Spike Warning — bearish, risk_regime, long horizon
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-10.9%)
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Low Volume Rally Warning — bearish, volume, short horizon (0.61x)
- Uptrend Structure Active — bullish, trend, long horizon
Both carry 3 more signals that do not separate them: ADX Trend Strengthening, ATR Expansion - Breakout Mode, TRIX Bullish Signal.
UFPT leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +5.89%, AIQ 0 points).
Price and the AIQ Score both moved up over the latest session (price +2.74%, AIQ +1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1PRCT closes the Value gap — currently 23 points behind, the largest single contributor to UFPT's edge.
- 2PRCT's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3UFPT's conflicting signal state resolves bearish — it currently carries 5 bullish and 2 bearish rules at once.
- 4The narrowing continues — the lead has already given back 6 points over 30 sessions, and a further 19-point move would eliminate UFPT's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
Split| Metric | PRCT | UFPT |
|---|---|---|
| Revenue growth (YoY) | 4% | -0.9% |
| EPS growth (YoY) | 2.1% | -1.1% |
| Gross margin | 64.7% | 28.9% |
| Operating margin | -33.6% | 15.5% |
| Return on equity (TTM) | -8.1% | 4.2% |
| Debt to equity | 0.23 | 0.24 |
Performance
Split across windows| Metric | PRCT | UFPT |
|---|---|---|
| 1 week (5 sessions) | 15.4% | 0.5% |
| 1 month (20 sessions) | 35.5% | 4.6% |
| 3 months (63 sessions) | 12.8% | -5.1% |
| 6 months (126 sessions) | -8.9% | 42.6% |
| Year to date | -24.3% | 37.4% |
| 1 year (252 sessions) | -22.7% | 28.6% |
Technicals
PRCT has the stronger structure| Metric | PRCT | UFPT |
|---|---|---|
| RSI (14) | 69 | 52.7 |
| ADX (14) | 36.7 | 25.2 |
| Price vs 50-day | 29% | 4.3% |
| Price vs 200-day | 3.9% | 21.2% |
| Volatility (1M, annualized) | 64% | 78.6% |
Risk
UFPT is the more resilient| Metric | PRCT | UFPT |
|---|---|---|
| Beta | 1.01 | 1.59 |
| Sharpe ratio | -0.11 | 0.69 |
| Sortino ratio | -0.15 | 1.2 |
| Max drawdown | -53.8% | -30.7% |
| Current drawdown | -34.1% | -8.9% |
| Annualized volatility | 65.9% | 50.8% |
| Value at risk (95%) | -6% | -3.7% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, PRCT or UFPT?
On the Algovestiq AIQ Score, UFPT is the stronger of the two as of Nov 18, 2026, scoring 68 against PRCT's 49. The edge comes from value and momentum. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is PRCT or UFPT the better buy right now?
UFPT carries the stronger systematic profile as of Nov 18, 2026, and the comparison is rated Competitive — 3 of 5 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor UFPT over PRCT?
The composite weights Quality, Value, Momentum and Risk Resilience. UFPT leads Value by 23 points; UFPT leads Momentum by 21 points; UFPT leads Quality by 18 points. UFPT leads on all four AIQ factor dimensions. Value is itself one of those four, so the sweep is not explained by PRCT simply being cheaper — it warrants extra scrutiny for unmodeled catalysts, forward expectations or event risk the factors do not capture.
Which has more analyst upside, PRCT or UFPT?
Analyst price targets imply +19.1% upside for PRCT and not covered for UFPT. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, PRCT or UFPT?
UFPT is the better-valued of the two on the peer-relative Value factor. UFPT on the peer-relative Value factor, by 23 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, PRCT or UFPT?
PRCT on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, PRCT or UFPT?
UFPT on the Momentum factor, by 21 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, PRCT or UFPT?
UFPT is the more resilient of the two, so the other name carries the higher downside risk. UFPT on Risk Resilience, by 11 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is PRCT more profitable than UFPT?
The profitability evidence is mixed: gross margin 64.7% vs 28.9%; operating margin -33.6% vs 15.5%; ttm roe -8.1% vs 4.2%. PRCT leads on one measure and UFPT on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is UFPT's lead over PRCT getting stronger or weaker?
UFPT lead: Weakening — the AIQ differential moved from 25 to 19 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-01 and 2026-11-18. The lead has not changed hands in that window.
What would change the PRCT vs UFPT verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: PRCT closes the Value gap — currently 23 points behind, the largest single contributor to UFPT's edge; PRCT's Death Cross Active resolves — a bearish trend rule currently active against it; UFPT's conflicting signal state resolves bearish — it currently carries 5 bullish and 2 bearish rules at once; the narrowing continues — the lead has already given back 6 points over 30 sessions, and a further 19-point move would eliminate UFPT's advantage entirely.
What do the current signals say about PRCT and UFPT?
PRCT: 4 bullish / 1 bearish / 2 neutral, conflicted. UFPT: 5 bullish / 2 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on PRCT is Death Cross Active (bearish, long horizon). On UFPT it is Golden Cross Active (bullish, long horizon).
Compare PRCT and UFPT with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.